A single injection of AAV gene therapy delivered a working OTOF gene and improved hearing in ten patients within weeks, researchers report. The results are striking for one rare f…
Eli Lilly has inked an exclusive research and licensing deal with Seamless Therapeutics worth up to $1.12 billion to develop programmable recombinase gene-editing therapies for in…
A new study links rare CPD gene mutations to congenital hearing loss and shows that restoring arginine–nitric oxide signaling — with supplements or sildenafil — rescues auditory c…
We use cookies
We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
